2020 MOFFATT, Christie
Archiving web content on the Coronavirus Disease (Covid-19).
https://circulatingnow.nlm.nih.gov/2020/03/26/archiving-web-content-on-the-coronavirus-disease-covid-19/ "The National Library of Medicine is archiving web and social media documenting the Coronavirus (COVID-19) outbr…
GMN 12156 · https://historyofmedicine.com/id/14366
2020 DOCUMENTING THE NOW
Documenting COVID-19, [a collaborative document.]
https://docs.google.com/document/d/1v5tso8spFq6SpW53h2OJULcdRoPEbyI6xpah31kW-H0/edit [I copied this document into this database on April 9, 2020.] "Documenting COVID-19 "https://bit.ly/doc-covid19 #doccovid19 This is …
GMN 12157 · https://historyofmedicine.com/id/14367
2020 TOPOS.COM
COVID-19 COMPILER. MAP
https://covid19.topos.com/ "COVID-19 Compiler aims to display relevant data about the novel coronavirus outbreak in the United States. "Our goal is to provide a multidimensional view of covid-19’s impact in counties a…
GMN 12186 · https://historyofmedicine.com/id/14396
2020 APUZZO, Mark (1978 – ); KIRKPATRICK, David D. (1970 – )
Covid-19 changed how the world does science, together. Never before, scientists say, have so many of the world's researchers focused so urgently on a single topic. Nearly all other research has ground to a halt.
April 1, 2020. https://www.nytimes.com/2020/04/01/world/europe/coronavirus-science-research-cooperation.html "Using flag-draped memes and military terminology, the Trump administration and its Chinese counterparts hav…
GMN 12190 · https://historyofmedicine.com/id/14400
2020 POLACK, Fernando P.; THOMAS, Stephen J.; KITCHIN, Nicholas; ET AL
Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.
BNT162b2 is synonomous with the Pfizer BioNTech mRNA Covid-19 vaccine. The Pfizer-BioNTech mRNA vaccine was produced from theoretical design to finished product and distribution in less than one year. This was the fir…
GMN 13506 · https://historyofmedicine.com/id/15781
2020 ROTHE, Camilla (1974 – ); SCHUNK, Mirjam; SOTHMANN, Peter; ET AL
Correspondence. Transmission of 2019 nCoV infection from an asymptomatic contact in Germany.
Posted online 1-30-20, updated 2-6-20, and published in print on March 5, 2020. First report of the "asymptomatic transmission" of Covid-19. The authors wrote, “The fact that asymptomatic persons are potential sources…
GMN 13519 · https://historyofmedicine.com/id/15794
2020 BAUM, Alina; AJITHDOSS, Dharani K.; KYRATSOUS, Christos A.; ET AL
REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters.
The authors, working at Regeneron, showed that a cocktail of two potent neutralizing monoclonal antibodes reduced virus load in the airways and diminshed viral induced pathological sequelae when given both as a prophy…
GMN 13523 · https://historyofmedicine.com/id/15799
2020 PÄÄBO, Svante (1955 – ); ZEBERG, Hugo
The major genetic risk factor for severe COVID-19 is inherited from Neanderthals.
Expanding on previous findings by a genome wide association study of severe COVID-19, specifically with respiratory failure which had found that a gene cluster residing on chromosome 3 had a significant association wi…
GMN 14098 · https://historyofmedicine.com/id/16409
2021 SLAVITT, Andrew M.
Preventable: The inside story of how leadership failures, politics, and selfishness doomed the U.S. coronavirus response.
GMN 13401 · https://historyofmedicine.com/id/15673
2021 BADEN, Lindsey Robert; EL SAHLY, Hana M.; ESSINK, Brandon; ET AL
Efficacy and safety of the mRNA-1273 SARSCov-2 vaccine.
mRNA-1273 is synonymous with the Moderna mRNA Covid-19 vaccine. The Moderna mRNA vaccine was produced from theoretical design to finished product and distribution in less than one year. This was the first published pa…
GMN 13507 · https://historyofmedicine.com/id/15782
2021 WEINREICH, David. M.; SIVAPALASINGAM, Sumathi; NORTON, Thomas; ET AL
REGN-COV-2, a neutralizing antibody cocktail, in outpatients with Covid-19.
The authors showed that the Regeneron antibody cocktail has a low incidence of side effects and a profound and rapid effect on viral load, with most reduction occurring within 48 hours, even in patents with the highes…
GMN 13524 · https://historyofmedicine.com/id/15800
2021 HALL, Robert "Bob" (1944 – ); DIAMOND, Judy; ET AL
C'rona pandemic comics.
https://worldofviruses.unl.edu/crona-comix/
GMN 13677 · https://historyofmedicine.com/id/15959
2021 OWEN, Dafydd R.; ALLERTON, Charlotte M. N.; ANDERSON, Annaliesa S.
An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.
The authors showed how a coronavirus specific protease inhibitor designed in the lab, that could be administered by mouth to humans, achieved excellent plasma concentrations and antiviral potency. This drug, marketed …
GMN 14023 · https://historyofmedicine.com/id/16330
2022 CARLSON, Colin J. (1996 – ); ALBERY, Gregory F.; MEROW, Cory; ET AL
Climate change increases cross-species viral transmission risk.
1) Using a phylogeographical model of the mammal-virus network, and projections of geographical range shifts, the authors assert that 3,139 mammal species will aggregate in new combinations at high elevations, seeking…
GMN 14049 · https://historyofmedicine.com/id/16359
